Quick Answer
Bicara Therapeutics Inc. reported Total Assets of $430.99 million for fiscal year 2025.
Bicara Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $430.99M | -15.5% |
| 2024 | $510.00M | +118.0% |
| 2023 | $233.98M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $424.69M | -19.0% | -6.4% |
| June 30, 2025 | $453.59M | — | -5.1% |
| March 31, 2025 | $478.08M | — | -6.3% |
| December 31, 2024 | $510.00M | +118.0% | -2.7% |
| September 30, 2024 | $524.17M | — | +124.0% |
| December 31, 2023 | $233.98M | — | — |
- Bicara Therapeutics Inc. showed a decrease of -15.5% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Bicara Therapeutics Inc.’s total assets has grown by 84.2% (from $233.98 million to $430.99 million).
- The most recent figure is from Bicara Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: